You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 16, 2025

Details for Patent: 8,470,368


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,470,368
Title:Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
Abstract: A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative is herein disclosed and described.
Inventor(s): Kositprapa; Unchalee (Davie, FL), Goldfarb; Robert I. (Golden Beach, FL), Cardinal; John R. (Tamarac, FL), Nangia; Avinash (Weston, FL)
Assignee: Watson Pharmaceuticals, Inc. (Corona, CA)
Application Number:13/151,653
Patent Claim Types:
see list of patent claims
Composition; Compound; Dosage form; Formulation; Device;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 8,470,368

Introduction

Understanding the scope and claims of a patent is crucial for determining its validity, potential infringement, and overall impact on the market. This article will delve into the specifics of United States Patent 8,470,368, focusing on its claims, the patent landscape, and relevant legal and technical aspects.

Patent Overview

United States Patent 8,470,368, titled "Pharmaceutical Drug Products," is associated with pharmaceutical formulations and methods. Here is a brief overview of the patent:

  • Title and Abstract: The patent pertains to specific pharmaceutical drug products, including their composition, formulation, and methods of administration. The abstract provides a summary of the invention, highlighting the key aspects of the drug products[5].

Claims Analysis

The claims section of a patent is critical as it defines the scope of the invention and what is protected by the patent.

Independent Claims

Independent claims are standalone and do not rely on other claims. They broadly define the invention and are often the most important claims in a patent. For example, Claim 1 of the '368 patent might describe the overall composition of the pharmaceutical drug product, including the active ingredients and excipients.

Dependent Claims

Dependent claims build upon independent claims and provide additional details or limitations. These claims narrow down the scope of the invention and can include specific embodiments or variations of the independent claims. For instance, a dependent claim might specify a particular dosage form or a method of manufacturing the drug product[5].

Claim Construction

Claim construction is the process of interpreting the meaning of the claims in a patent. This is a legal determination that can significantly impact the validity and enforceability of the patent.

  • Legal Framework: Claim construction is a question of law reviewed de novo on appeal. The court must determine the meaning of the claim terms based on the patent specification, the prosecution history, and any extrinsic evidence[2].
  • Examples: In the context of the '368 patent, claim construction would involve analyzing the language used in the claims to understand what specific pharmaceutical drug products are covered. For instance, if a claim mentions a "controlled release formulation," the court would need to define what constitutes a "controlled release" in this context.

Patent Landscape

The patent landscape includes all relevant patents and prior art that could impact the validity or enforceability of the '368 patent.

Prior Art

Prior art refers to any publicly available information that existed before the filing date of the patent. This can include earlier patents, publications, and other forms of public disclosure.

  • Global Dossier: Tools like the Global Dossier provided by the USPTO allow users to view the file histories of related applications from participating IP Offices, which can help identify prior art and understand the global patent landscape[4].
  • International Patent Offices: Searching databases from other international intellectual property offices, such as the European Patent Office (EPO) or the Japan Patent Office (JPO), is essential to ensure that the invention is novel and non-obvious over global prior art[4].

Related Patents

Other patents in the same field can provide insight into the competitive landscape and potential infringement issues.

  • Patent Families: Using tools like the Common Citation Document (CCD) can help consolidate citation data from multiple offices, making it easier to visualize the patent family and related applications[4].
  • Patent Assignment Search: This tool can reveal changes in ownership, which might affect the enforcement or licensing of the patent[4].

Legal Challenges and Validity

Patents are subject to various legal challenges that can affect their validity.

Inter Partes Review (IPR)

IPR is a process where the Patent Trial and Appeal Board (PTAB) reviews the validity of a patent based on prior art. This can be a significant challenge to the patent's validity.

  • Example: In cases like Vascular Solutions LLC v. Medtronic, Inc., multiple IPR petitions were filed, and the PTAB determined some claims to be unpatentable, while others remained valid[2].

Infringement Litigation

Patent infringement litigation involves determining whether another party's product or process infringes on the claims of the patent.

  • Example: The '368 patent could be involved in litigation if another company files an Abbreviated New Drug Application (ANDA) with the FDA for a similar drug product, as seen in cases involving generic pharmaceutical companies[5].

Technical Aspects

Understanding the technical aspects of the patent is crucial for both the inventor and potential infringers.

Pharmaceutical Formulations

The '368 patent likely involves detailed descriptions of pharmaceutical formulations, including the active ingredients, excipients, and manufacturing processes.

  • Controlled Release: The patent might describe specific methods for achieving controlled release of the active ingredients, which is a critical aspect of pharmaceutical drug products[5].

Regulatory Compliance

Pharmaceutical patents must comply with regulatory requirements, such as those set by the FDA.

  • ANDA Filings: Generic drug manufacturers must file ANDAs, which include certifications regarding the validity of the relevant patents. This can lead to litigation if the generic manufacturer believes the patents are invalid or not infringed[5].

Economic and Market Impact

The economic and market impact of a patent can be significant.

Patent Scope Measurements

The USPTO's Patent Claims Research Dataset provides insights into patent scope, which can help in understanding the economic impact of a patent. This dataset includes measures of patent scope derived from the claims and dependency relationships between them[3].

Licensing and Enforcement

A strong patent with a clear scope can be a valuable asset for licensing and enforcement. Companies may license their patents to other entities, generating revenue, or enforce their patents against infringers to protect their market share.

Key Takeaways

  • Claims Analysis: Understanding the independent and dependent claims is essential for determining the scope of the patent.
  • Claim Construction: Legal interpretation of claim terms is critical for validity and enforceability.
  • Patent Landscape: Prior art and related patents must be thoroughly searched to ensure novelty and non-obviousness.
  • Legal Challenges: Patents are subject to IPR and infringement litigation, which can affect their validity.
  • Technical Aspects: Detailed understanding of the technical aspects, such as pharmaceutical formulations, is necessary.
  • Economic Impact: The patent's scope and enforcement can have significant economic and market implications.

FAQs

Q: What is the purpose of claim construction in patent law? A: Claim construction is the process of interpreting the meaning of the claims in a patent to determine their scope and validity.

Q: How can I search for prior art related to a specific patent? A: You can use tools like the Global Dossier, Common Citation Document, and databases from international intellectual property offices to search for prior art.

Q: What is an Abbreviated New Drug Application (ANDA)? A: An ANDA is a submission to the FDA for approval to manufacture and market a generic version of a drug product.

Q: How does the USPTO's Patent Claims Research Dataset help in understanding patent scope? A: The dataset provides detailed information on claims, including claim-level statistics and document-level statistics, which help in measuring patent scope.

Q: What is the significance of inter partes review (IPR) in patent law? A: IPR is a process where the PTAB reviews the validity of a patent based on prior art, which can lead to the invalidation of some or all claims of the patent.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 8,470,368

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

International Family Members for US Patent 8,470,368

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Argentina 054238 ⤷  Try for Free
Australia 2003272504 ⤷  Try for Free
Australia 2004283059 ⤷  Try for Free
Australia 2006232993 ⤷  Try for Free
Australia 2011202162 ⤷  Try for Free
Brazil PI0414471 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 6 of 6 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.